Large-scale testing (Phase 3)Study completedNCT00338117
What this trial is testing
Safety and Efficacy of High Dose, Rapid Titration Galantamine in Patients With Alzheimer's Disease
Who this might be right for
Alzheimer's DiseaseDementia
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 554